Leadership Transition at Ledger Run
Ledger Run is entering a new phase of growth as it announces a significant leadership transition. Gary Lubin, the Founder and long-time CEO, has decided to retire while continuing his contributions as a Board member. Meanwhile, John Chinnici has been appointed as the new Chief Executive Officer, signaling a fresh start for the company.
A Legacy of Innovation
Throughout his time at Ledger Run, Gary Lubin has played a pivotal role in establishing the company as a cornerstone in clinical trial operations. Under his guidance, Ledger Run cultivated a culture of dedication to supporting the development of groundbreaking medical treatments. His experience spanning more than forty years in the industry has seen him not only found companies but also lead transformative initiatives. This legacy of growth and commitment to excellence will undoubtedly influence John Chinnici as he takes the helm.
Introduction of the New CEO
John Chinnici comes to Ledger Run equipped with over twenty-five years of experience in scaling software and services within the life sciences sector. Previously with firms such as Accenture, IBM, and Veeva Systems, he has a comprehensive background that aligns perfectly with Ledger Run’s strategic goals. Most recently, John played a key role leading the Insights division at Inovalon, a prominent healthcare software company.
Excitement for Future Prospects
Gary Lubin expressed gratitude for the time spent leading the company, stating, "It has been an honor to have founded and served as its CEO for all these years, and I am excited to have John take the reins." With a committed team and a robust technology platform, there is significant optimism for Ledger Run's future under Chinnici’s leadership.
Shaping the Vision Ahead
As Ledger Run continues its mission to enhance clinical trial operations, Chinnici aims to uphold the values instilled by his predecessor. He aims to continue nurturing the strong customer relationships built over the years. Chinnici commented on this unique opportunity: "I am excited to build on the great legacy Gary has established, for the privilege to serve Ledger Run's tremendous customer base, and the opportunity to work with the amazing Ledger Run team."
Board Comments on Changes
John Durrett, a Partner at Blue Star Innovation Partners and an Executive Sponsor for Ledger Run, commended Gary Lubin for his leadership and vision. He noted, "The Board is delighted to welcome John as the new CEO. He is well-suited to lead the company as we continue to innovate and provide transformative technologies to the industry." This support from the Board signifies a strong foundation as the company moves forward.
About Ledger Run
Ledger Run is at the forefront of revolutionizing clinical trial business operations with its sophisticated suite of trial management solutions. With ClinRun, their next-generation software, the company streamlines budgeting, contracting, payments, and forecasting processes, ensuring efficiency and reducing errors. It fosters seamless engagement among sponsors, CROs, and investigator sites, ultimately enhancing the oversight of complex studies.
Frequently Asked Questions
Who is the new CEO of Ledger Run?
John Chinnici has been appointed as the new CEO of Ledger Run, succeeding founder Gary Lubin.
How long did Gary Lubin serve as CEO?
Gary Lubin served as CEO for several decades, helping to shape the growth and vision of Ledger Run.
What is Ledger Run known for?
Ledger Run is known for providing advanced software solutions for clinical trials, particularly its ClinRun platform.
What previous experience does John Chinnici have?
John Chinnici has over 25 years of experience in the life sciences industry, having worked with firms like Accenture, IBM, and Veeva Systems.
What is the mission of Ledger Run?
The mission of Ledger Run is to transform clinical trial operations through innovative technology that enhances efficiency and accelerates the development of new medical treatments.
